Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents MarineMax in Its US$1.5 Billion Sale to Blackstone Infrastructure Portfolio Company, Safe HarborAugust 10, 2026Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private PlacementJuly 17, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026Legal Implications in AI Development and Deployment: Training Data and Grounding DataJuly 9, 2026Sidley Represents Abbisko Therapeutics in Its US$1.9 Billion Strategic Collaboration With Eli Lilly and Co.July 2, 2026Sidley Advises on the Hong Kong IPO of Shenzhen Senior Technology MaterialJune 23, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory